Losartan potassium and Multi-organ failure - a phase IV clinical study of FDA data

Summary:

Multi-organ failure is reported as a side effect among people who take Losartan potassium (losartan potassium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Multi-organ failure when taking Losartan potassium. It is created by eHealthMe based on reports of 50,026 people who have side effects when taking Losartan potassium from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Multi-organ failure?

Multi-organ failure (multisystem organ failure) is found to be associated with 1,395 drugs and 2,278 conditions by eHealthMe. Check the latest studies of Multi-organ failure.

On Jul, 06, 2026

50,026 people reported to have side effects when taking Losartan potassium.
Among them, 58 people (0.12%) have Multi-organ failure.

Could Losartan potassium cause Multi-organ failure?

Among these 58 people:

How long have people been on Losartan potassium when they have Multi-organ failure? *

What is the gender of people who have Multi-organ failure when taking Losartan potassium? *

female: 50.88 %
male: 49.12 %

What is the age of people who have Multi-organ failure when taking Losartan potassium? *

What are other drugs people take besides Losartan potassium? *

What are other side effects people have besides Multi-organ failure? *

Acute Kidney Failure: 22 people, 37.93%
Pneumonia: 10 people, 17.24%
Diarrhea: 8 people, 13.79%
Injury: 8 people, 13.79%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 13.79%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 8 people, 13.79%
Pain: 7 people, 12.07%
Hypotension (abnormally low blood pressure): 7 people, 12.07%
Stress And Anxiety: 6 people, 10.34%
Dyspnea (difficult or laboured breathing): 6 people, 10.34%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 8.62%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 5.17%
Pain: 3 people, 5.17%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 5.17%
Diabetes: 3 people, 5.17%
Headache (pain in head): 2 people, 3.45%
High Blood Cholesterol: 2 people, 3.45%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 3.45%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 3.45%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Multi-organ failure?

- Check whether Multi-organ failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Losartan potassium:

Losartan potassium (51,511 reports)

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multi-organ failure:

Multi-organ failure (1,395 drugs)

Browse all the conditions that are associated with Multi-organ failure:

Multi-organ failure (2,278 conditions)

Related publications that referenced our studies

Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.